3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Polycythemia Vera
3
Venous Thromboembolism
2
Thrombocythemia, Essential
2
Rectal Neoplasms
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Adenoma
2
Vascular Diseases
1
Thrombosis
1
Thrombocytopenia
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Pathologic Processes
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Lymphoma, Follicular
1
Liver Cirrhosis
1
Ischemic Stroke
1
Interventions
Bevacizumab
5
Leucovorin
4
Irinotecan
4
Fluorouracil
4
Gemcitabine
3
Capecitabine
3
napabucasin
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
linifanib
1
encorafenib
1
apatinib
1
Sorafenib
1
Polyamines
1
Oxaliplatin
1
Oviposition
1
NUC-1031
1
Levoleucovorin
1
Everolimus
1
Drug Therapy
1
Drainage
1
Cisplatin
1
Cetuximab
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Digestive System Neoplasms
×
Aspirin
×
Clear all
NCT03464305
2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3
Active not recruiting
148 enrolled